0001179110-17-015217.txt : 20171211 0001179110-17-015217.hdr.sgml : 20171211 20171211170822 ACCESSION NUMBER: 0001179110-17-015217 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171207 FILED AS OF DATE: 20171211 DATE AS OF CHANGE: 20171211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Knowlton Calvin H CENTRAL INDEX KEY: 0001685833 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37888 FILM NUMBER: 171250185 MAIL ADDRESS: STREET 1: 228 STRAWBRIDGE DRIVE STREET 2: SUITE 100 CITY: MOORESTOWN STATE: NJ ZIP: 08057 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tabula Rasa HealthCare, Inc. CENTRAL INDEX KEY: 0001651561 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 465726437 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 228 STRAWBRIDGE DRIVE STREET 2: SUITE 100 CITY: MOORESTOWN STATE: NJ ZIP: 08057 BUSINESS PHONE: 866-648-2767 MAIL ADDRESS: STREET 1: 228 STRAWBRIDGE DRIVE STREET 2: SUITE 100 CITY: MOORESTOWN STATE: NJ ZIP: 08057 4 1 edgar.xml FORM 4 - X0306 4 2017-12-07 0 0001651561 Tabula Rasa HealthCare, Inc. TRHC 0001685833 Knowlton Calvin H 228 STRAWBRIDGE DRIVE SUITE 100 MOORESTOWN NJ 08057 1 1 1 0 Chief Executive Officer Common Stock 2017-12-07 4 S 0 8000 27.72 D 910362 D Common Stock 2017-12-08 4 S 0 57500 25.85 D 852862 D Common Stock 2017-12-08 4 S 0 57500 25.85 D 817617 I Held by spouse. This sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2017. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.35 to $28.02, inclusive. The reporting person undertakes to provide to Tabula Rasa HealthCare, Inc., any security holder of Tabula Rasa HealthCare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote (2) to this Form 4. The sale of these shares was effected as part of an underwritten public offering completed on December 8, 2017 of common stock of the Company in which the Reporting Person was a selling stockholder. The price represents the public offering price of $27.50 less the underwriters' discount. /s/ Brian W. Adams, Attorney-in-fact 2017-12-11